Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Open accessThe DOI matches its Crossref record; 235 of the 236 references it cites were found in a registry or an index; 50 of the 187 sources its claims cite were checked for support.
Abstract
Organisms are continually exposed to exogenous and endogenous sources of reactive oxygen species (ROS) and other oxidants that have both beneficial and deleterious effects on the cell. ROS have important roles in a wide range of physiological processes; however, high ROS levels are associated with oxidative stress and disease progression. Oxidative stress has been implicated in nearly all major human diseases, from neurogenerative diseases and neuropsychiatric disorders to cardiovascular disease, diabetes, and cancer. Antioxidant defence systems have evolved as a means of protection against oxidative stress, with the transcription factor Nrf2 as the key regulator. Nrf2 is responsible for regulating an extensive panel of antioxidant enzymes involved in the detoxification and elimination of oxidative stress and has been extensively studied in the disease contexts. This review aims to provide the reader with a general overview of oxidative stress and Nrf2, including basic mechanisms of Nrf2 activation and regulation, and implications in various major human diseases.
Overview
CoChat Summary
TL;DR
This narrative review summarizes oxidative stress and the Keap1-Nrf2 antioxidant pathway, covering Nrf2 activation, regulation, and interacting proteins. It highlights Nrf2 as the master regulator of antioxidant and phase II enzymes, with protective roles in many diseases but also a harmful “dark side” in cancer.
Key findings
- Nrf2 is the key transcriptional regulator of ARE-driven antioxidant and phase II enzyme genes; under basal conditions Nrf2 has a short half-life of only 10–30 min, and Keap1 mediates its Cul3-dependent ubiquitination and proteasomal degradation.
- Keap1 senses oxidative stress through reactive cysteines: human Keap1 contains 27 cysteine residues, about 4% of its amino acid content versus a 2% average for the human proteome; Cys273 and Cys288 are required for sensing oxidative stress under basal and stress conditions, while Cys151 may be required only during oxidative stress.
- The Keap1-Nrf2 two-site recognition model depends on the high-affinity ETGE motif and low-affinity DLG motif; the ETGE motif has a binding affinity two orders of magnitude higher than the DLG motif, making DLG an “on/off switch” for Nrf2 ubiquitination.
- Nrf2 is implicated in major human diseases: reduced nuclear Nrf2 is observed in Alzheimer’s disease brain regions; Nrf2 pathway alterations occur in 34% of squamous cell lung cancer specimens; and Nrf2 hyperactivation can promote chemoresistance to drugs such as cisplatin, 5-fluorouracil, docetaxel, and bortezomib.
Methods
- Design: narrative review providing a general overview of oxidative stress, Nrf2 mechanisms, and implications in human disease.
- Data or sample: no primary experimental data or human/animal sample; the paper synthesizes published literature and cites prior studies, reviews, and model-organism findings.
- Main analysis: descriptive synthesis of ROS/RNS biology, antioxidant enzymes, ARE regulation, canonical and non-canonical Keap1-Nrf2 regulation, Nrf2-interacting proteins, and disease associations including neurodegenerative disease, neuropsychiatric disorders, cardiovascular disease, diabetes, cancer, inflammation, and aging.
Limitations
- The paper does not state formal limitations; it describes the review as a “general overview” and notes that several topics are “briefly discussed” or “beyond the scope of this review.”
- Evident from the text: as a narrative review, it lacks a systematic search strategy, predefined inclusion criteria, or quantitative synthesis, and it presents no primary data.
- Evident from the text: disease sections are broad and selective rather than exhaustive, and the authors repeatedly refer readers to other reviews for more detailed discussion.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
23 Valid · 5 Not valid · 72 Not checked · 17 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“WTX is also involved in oxidative stress regulation through its competitive binding to the Keap1, which inhibits Nrf2 ubiquitination [84].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.7. Keap1-Interacting Proteins
What the sources say
- Disputedcites [84] Copple, 2010, Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The Discussion attributes competitive binding to Keap1 and reduced Nrf2 ubiquitination to SQSTM1 (p62), not WTX. The paper’s stated mechanism therefore identifies a different protein from the one in the citing sentence; no page number is available in our copy. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Chronic oxidative stress and the resultant oxidative damage have been implicated in many human diseases including cardiovascular disease, neurodegenerative diseases, diabetes, cancer, and the aging process [18,19,20,21,22].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 1. Oxidative Stress > 1.2. Oxidative Stress
What the sources say
- Partly supportedcites [18] Reuter, 2010, Oxidative stress, inflammation, and cancer: How are they linked?, Free Radic. Biol. Med. sourceExperimental — accuracy not yet measured
The Introduction links sustained oxidative stress and cellular damage to cancer, and describes increased oxidative stress and accumulated molecular damage in aging. The passages from the body of our copy do not substantiate the additional claims about cardiovascular disease, neurodegenerative diseases, or diabetes; those conditions appear in the retrieved reference titles. (LLM, conf=0.84)
- Partly supportedcites [19] Alfadda, 2012, Reactive Oxygen Species in Health and Disease, J. Biomed. Biotechnol. sourceExperimental — accuracy not yet measured
The Introduction (section 1; page unavailable) links ROS to cancer, diabetes, cardiovascular disease, and aging, and section 5.3 links oxidative stress to diabetic complications. The passages found do not establish the claimed link to neurodegenerative diseases or characterize the whole disease list specifically as consequences of chronic oxidative stress and resultant damage. (LLM, conf=0.84)
- Partly supportedcites [20] Asmat, 2016, Diabetes mellitus and oxidative stress—A concise review, Saudi Pharm. J. sourceExperimental — accuracy not yet measured
The 'Oxidative stress and antioxidants' section links oxidative damage to a wide variety of diseases, notably cancer and heart disease. 'Oxidative stress and diabetic complications' also links oxidative stress to diabetes and coronary artery disease. Our copy does not establish the claimed link to neurodegenerative diseases or aging; it mentions aging as a possible factor contributing to oxidative stress, not as a resulting condition. No page numbers are available in our copy. (LLM, conf=0.86)
- Supportedcites [21] Liguori, 2018, Oxidative stress, aging, and diseases, Clin. Interv. Aging source
The sections on cardiovascular disease, diabetes, cognitive impairment and dementia, and cancer each link oxidative stress or oxidative damage to the named conditions. The section on the theory of aging describes accumulated oxidative damage as a proposed explanation for age-related functional loss. Page numbers are not available in our copy. (LLM, conf=0.92)
- Not checked yetcites [22] Barnham, 2004, Neurodegenerative diseases and oxidative stress, Nat. Rev. Drug Discov. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Nrf2 regulates the expression of a multitude of antioxidant and phase II enzyme genes and is negatively regulated by Kelch-like ECH-associated protein (Keap1) [49], a substrate adaptor protein that binds to Nrf2 in the cytosol to facilitate its polyubiquitination by the Cullin 3 (Cul3) E3 ubiquitin ligase for proteasomal degradation [50,51,52].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.1. Keap1-Nrf2 Signalling
What the sources say
- Supportedcites [49] Itoh, 1999, Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, Genes Dev. source
The Abstract states that Keap1 suppresses Nrf2 transcriptional activity by binding its amino-terminal regulatory domain. The Discussion also describes Nrf2 as sequestered in the cytoplasm through its association with Keap1. This source is cited for negative regulation by Keap1; the later Cul3, polyubiquitination, and degradation mechanism is attached to citations [50–52], not this one. (LLM, conf=0.94)
- Supportedcites [50] Nguyen, 2003, Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome, J. Biol. Chem. source
Citation [49] is attached to the claim that Keap1 negatively regulates Nrf2. The paper describes Keap1 retaining Nrf2 in the cytoplasm and says that their dissociation allows Nrf2 to enter the nucleus (introductory passage and Discussion). The subsequent Cul3 polyubiquitination mechanism is attached to citations [50–52], not this source. (LLM, conf=0.92)
- Supportedcites [51] Kobayashi, 2004, Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2, Mol. Cell. Biol. source
The Abstract states that Keap1 retains Nrf2 in the cytoplasm, binds it directly, and acts as an adaptor for Cul3-based E3 ligase in its proteasomal degradation. The Results report ubiquitin-chain conjugation and show that Nrf2 ubiquitination depends on its interaction with Keap1. (LLM, conf=0.93)
- Not checked yetcites [52] McMahon, 2003, Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression, J. Biol. Chem. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Oxidative damage has been implicated in all major neurodegenerative diseases including Alzheimer’s disease (AD) [108,109], Parkinson’s disease (PD) [110,111], Huntington’s disease (HD) [112,113], amyotrophic lateral sclerosis (ALS) [114], and multiple sclerosis (MS) [115].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 3. Nrf2 in Human Disease > 3.1. Neurodegenerative Disease
What the sources say
- Supportedcites [108] Smith, 2000, Oxidative stress in Alzheimer’s disease, Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. source
This source is cited for the Alzheimer’s disease portion of the sentence, not for the other listed diseases. Section 2, “Oxidative damage,” describes oxidative damage in AD, and the Conclusion states that oxidative stress plays an important role in AD pathogenesis. (LLM, conf=0.94)
- Supportedcites [109] Cioffi, 2019, Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease, J. Alzheimer’s Dis. JAD source
The sentence assigns separate citations to each disease; this source supports the Alzheimer’s disease portion. The Introduction reports early hallmarks of oxidative stress in AD, and “Oxidative Damage to Biomacromolecules in Alzheimer’s Disease” describes oxidative damage in AD brain tissue. The source need not support the other diseases, which have their own citations. (LLM, conf=0.92)
- Not checked yetcites [110] Dias, 2013, The Role of Oxidative Stress in Parkinson’s Disease, J. Park. Dis.
- Supportedcites [111] Blesa, 2015, Oxidative stress and Parkinson’s disease, Front. Neuroanat. source
The citation is attached to the Parkinson’s disease portion of the sentence, not the list of other diseases. The Introduction states that Parkinson’s disease is related to excess reactive oxygen species and that oxidative stress is thought to underlie cellular dysfunction and death in PD. (LLM, conf=0.94)
- Not checked yetcites [112] Browne, 1999, Oxidative stress in Huntington’s disease, Brain Pathol. source
- Supportedcites [113] Kumar, 2016, Oxidative Stress and Huntington’s Disease: The Good, the Bad, and the Ugly, J. Huntingt. Dis. source
The citation to this source is attached to Huntington’s disease, not to the other diseases in the sentence. The section “Is Oxidative Stress a Cause or a Consequence in HD Pathology?” reports increased oxidative damage in postmortem HD brains and describes oxidative stress as implicated in HD pathogenesis. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Nrf2 association requires the homodimerization of Keap1 [74].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.4. Keap1-Dependent Nrf2 Regulation
What the sources say
- Supportedcites [74] Zipper, 2002, The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm, J. Biol. Chem. source
The Discussion states that the integrity of the Keap1–Nrf2 complex depends on Keap1 dimerization and calls the BTB/POZ dimerization function a prerequisite for Nrf2 binding. The Results (Fig. 3B) also report reduced Nrf2 association with a Keap1 mutant deficient in homodimerization. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
67 more claims · 13 with their cited sources checked
Create a free account to see all 117 claims and to verify the 137 references still open.
- It may state two separate claims as one. 42
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The transcription factor Nrf2 acts as a central regulator of the host’s primary antioxidant defense system [73,74] and determines cellular fate during envenomation.”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 1. Oxidative Stress > 1.1. Reactive Oxygen Species
“superoxide radicals which are readily detoxified to hydrogen peroxide (H2O2) by antioxidant enzymes such as catalase and glutathione peroxidase.”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 1. Oxidative Stress > 1.3. Antioxidant Response Enzymes
“SODs are responsible for the dismutation (simultaneous oxidation and reduction) and breakdown of superoxide radicals into molecular oxygen and hydrogen peroxide”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.7. Keap1-Interacting Proteins
“In 2010, five independent groups discovered the interaction between p62 and Keap1 [77,78,79,80,81].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > References
“78. Baird L. Yamamoto M. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway Mol. Cell. Biol. 2020 40 e00099-20”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.7. Keap1-Interacting Proteins
“WTX is also involved in oxidative stress regulation through its competitive binding to the Keap1, which inhibits Nrf2 ubiquitination [84].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > References
“84. Copple I.M. Lister A. Obeng A.D. Kitteringham N.R. Jenkins R.E. Layfield R. Foster B.J. Goldring C.E. Park B.K. Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway”
Citations
Cites
1 retracted
Zhou, S., Ye, W., Duan, X., Zhang, M., & Wang, J. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2537-1 · Cited by 18
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Reactive oxygen species: Metabolism, oxidative stress, and signal transduction
Apel, K., & Hirt, H. (2004) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.55.031903.141701 · Cited by 11,723 · cited 3×
“Extensive or prolonged exposure to ROS results in oxidative stress, a deleterious process that damages lipi s, proteins, and nucleic acids in the cell, thereby inhibiting their normal function [2].”
BackgroundInfluentialPolazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Free Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680 · cited 1×
“RNS and ROS often act together to cause cellular damage [8].”
BackgroundOxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999 · cited 6×
“Nrf2-deficient mice showed marked reductions in the expression of the phase II enzyme GST α1 subunit and the antioxidant enzyme NQO1 [44], and ensuing studies demonstrated increased sensitivity to carcinogens and impaired detoxification of acetaminophen in Nrf2−/− mice [45–47].”
BackgroundInfluentialComprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Activation of apoptosis signalling pathways by reactive oxygen species
Redza-Dutordoir, M., & Averill-Bates, D. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.09.012 · Cited by 3,731
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 9×
“Nrf2 regulates the expression of a multitude of antioxidant and phase II enzyme genes and is negatively regulated by Kelch-like ECH-associated protein (Keap1) [49], a substrate adaptor protein that binds to Nrf2 in the cytosol to facilitate its polyubiquitination by the Cullin 3 (Cul3) E3 ubiquitin ligase for proteaso…”
BackgroundInfluentialSies, H., Berndt, C., & Jones, D. P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045037 · Cited by 3,520
Uttara, B., Singh, A., Zamboni, P., & Mahajan, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602823 · Cited by 3,378
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368 · cited 3×
“, a quiescent, non-dividing stage) due to activation of the p53-regulated cyclin-dependent kinase inhibitor p21, which halts cell cycle progression and inhibits DNA synthesis [23,24].”
BackgroundMutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778 · cited 2×
“Prothymosin α (ProTα/PTMA) is a small, highly charged protein involved in cell proliferation and survival through chromatin remodelling and anti-apoptotic activity [95,96]).”
BackgroundHayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654
Glutathione: overview of its protective roles, measurement, and biosynthesis
Forman, H. J., Zhang, H., & Rinna, A. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.006 · Cited by 2,636 · cited 1×
“GSH plays a critical role in protecting cells from oxidative damage through direct antioxidant activity or coupled to GPx enzymatic activity [37,38].”
BackgroundSignal transduction by reactive oxygen species
Finkel, T. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102095 · Cited by 2,322 · cited 1×
“At low to moderate levels, ROS plays an important role in normal cellular processes, serving as secondary messengers in intracellular signalling cascades that mediate cell growth, autophagy, inflammatory and immune function, and contribute to overall redox regulation [16,17].”
BackgroundKomatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K. I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2021 · Cited by 2,288
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224 · cited 2×
“Keap1 [49] belongs to the BTB-Kelch family of proteins which includes about 50 members, all of which assemble with the Cul3 E3 ubiquitin ligase and RING box protein-1 (Rbx1) to form the Cullin-RING E3 ubiquitin ligases (CRLs) involved in the ubiquitination of BTB-Kelch proteins, such as Keap1 [51,66].”
BackgroundZelko, I. N., Mariani, T. J., & Folz, R. J. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00905-x · Cited by 2,212 · cited 1×
“SOD isoenzymes include Cu/Zn-SOD (SOD1), Mn-SOD (SOD2), and extracellular (EC) SOD (SOD3) [31,32].”
BackgroundCytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.014 · Cited by 2,162
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Brigelius-Flohé, R., & Maiorino, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.020 · Cited by 1,904 · cited 1×
“Enzymes in the GPx family include GPx1 through 8, each with different expression patterns within the body [39].”
BackgroundNrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Kobayashi, E. H., Suzuki, T., Funayama, R., Nagashima, T., Hayashi, M., Sekine, H., Tanaka, N., Moriguchi, T., Motohashi, H., Nakayama, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11624 · Cited by 1,878
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Nrf2 signaling pathway: pivotal roles in inflammation
Ahmed, S. M. U., Luo, L., Namani, A., Wang, X. J., & Tang, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.005 · Cited by 1,794
Diversity of structures and properties among catalases
Chelikani, P., Fita, I., & Loewen, P. C. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3206-5 · Cited by 1,700 · cited 1×
“Catalase is found in nearly all living eukaryotic organisms and exists primarily within peroxisomes as well as in the mitochondria and nucleus [33].”
BackgroundZhang, Y., Talalay, P., Cho, C. G., & Posner, G. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2399 · Cited by 1,682
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607 · cited 9×
“Nuclear factor erythroid 2-related factor 2 (Nrf2) [48] is the transcriptional master regulator of cellular responses against oxidative stress.”
BackgroundInfluentialEffects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
Vallance, P., Collier, J., & Moncada, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91013-1 · Cited by 1,590
A standardized protocol for repeated social defeat stress in mice
Golden, S. A., Covington, H. E., Berton, O., & Russo, S. J. (2011) · Nature Protocols · doi:10.1038/nprot.2011.361 · Cited by 1,581
Diabetes mellitus and oxidative stress—A concise review
Asmat, U., Abad, K., & Ismail, K. (2016) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2015.03.013 · Cited by 1,570
Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro
Imlay, J. A., Chin, S. M., & Linn, S. (1988) · Science · doi:10.1126/science.2834821 · Cited by 1,555 · cited 1×
“Hydrogen peroxide may react with transition metals such as iron (Fe2+) to produce hydroxyl radicals via the Fenton reaction to further produce hydroxyl radicals (•OH) which are highly reactive toward all components of DNA molecules as well as lipids [13].”
BackgroundThe Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway
Baird, L., & Yamamoto, M. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00099-20 · Cited by 1,542
Unfolding the role of protein misfolding in neurodegenerative diseases
Soto, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1007 · Cited by 1,506
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502 · cited 3×
“Damaged mitochondria and activated microglia are major sources of ROS in the brain [105].”
BackgroundInfluentialZhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · cited 1×
“Cys273 and Cys288 are required for sensing oxidative stress under both basal and stress conditions, whereas Cys151 may be required only during oxidative stress conditions [53,54].”
BackgroundJain, A., Lamark, T., Sjøttem, E., Bowitz Larsen, K., Atesoh Awuh, J., Øvervatn, A., McMahon, M., Hayes, J. D., & Johansen, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118976 · Cited by 1,472 · cited 2×
“Within the nucleus, Keap1 binds to Nrf2 to facilitate its nuclear export and subsequent ubiquitination in the cytosol, thus allowing for attenuation of Nrf2 activity during the postinduction phase [86].”
BackgroundRushmore, T. H., Morton, M. R., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99004-6 · Cited by 1,464 · cited 8×
“HeLa cells overexpressing ProTα show increased Nrf2-mediated HMOX1 gene expression; however, overexpression of a mutant variant of ProTα that impairs Keap1-binding fails to upregulate HMOX1 [82], thereby demonstrating the role of ProTα in the expression of certain antioxidant genes.”
BackgroundInfluentialAn Overview of Nrf2 Signaling Pathway and Its Role in Inflammation
Saha, S., Buttari, B., Panieri, E., Profumo, E., & Saso, L. (2020) · Molecules · doi:10.3390/molecules25225474 · Cited by 1,388 · cited 1×
“Nrf2 plays numerous additional roles in inflammation that are summarized in review articles published by Ahmed et al. (2017) [199] and Saha et al. (2020) [200].”
BackgroundThe changing faces of glutathione, a cellular protagonist
Pompella, A., Visvikis, A., Paolicchi, A., Tata, V. D., & Casini, A. F. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00504-5 · Cited by 1,359 · cited 1×
“GSH plays a critical role in protecting cells from oxidative damage through direct antioxidant activity or coupled to GPx enzymatic activity [37,38].”
BackgroundMitochondrial metabolism of reactive oxygen species
Andreyev, A. Y., Kushnareva, Y. E., & Starkov, A. A. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0102-7 · Cited by 1,336
Induction of phase I, II and III drug metabolism/transport by xenobiotics
Xu, C., Li, C. Y.-T., & Kong, A.-N. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,279 · cited 1×
“Xenobiotic metabolism consists of phase I, phase II, and phase III enzymes involved in oxidation, conjugation/detoxification, and elimination, respectively [40,41].”
BackgroundKeap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S.-C., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,254 · cited 2×
“Keap1 [49] belongs to the BTB-Kelch family of proteins which includes about 50 members, all of which assemble with the Cul3 E3 ubiquitin ligase and RING box protein-1 (Rbx1) to form the Cullin-RING E3 ubiquitin ligases (CRLs) involved in the ubiquitination of BTB-Kelch proteins, such as Keap1 [51,66].”
BackgroundInflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155
Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases
Tan, B. L., Norhaizan, M. E., Liew, W.-P.-P., & Sulaiman Rahman, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01162 · Cited by 1,149
Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine
Radi, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804932115 · Cited by 1,142 · cited 1×
“Peroxynitrite is very reactive and readily attacks lipid molecules, resulting in lipid peroxidation and lipoprotein oxidation [3].”
BackgroundA Requirement for the Intercellular Messenger Nitric Oxide in Long-Term Potentiation
Schuman, E. M., & Madison, D. V. (1991) · Science · doi:10.1126/science.1720572 · Cited by 1,141 · cited 1×
“For example, nitric oxide produced by nitric oxide synthase (NOS) regulates blood vessel dilation and is involved in synaptic transmission in the brain [4,5].”
BackgroundMcMahon, M., Itoh, K., Yamamoto, M., & Hayes, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300931200 · Cited by 1,141
Ramos-Gomez, M., Kwak, M.-K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., & Kensler, T. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051618798 · Cited by 1,102
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., Herman, J. G., Baylin, S. B., Sidransky, D., Gabrielson, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030420 · Cited by 1,060
O'Dell, T. J., Hawkins, R. D., Kandel, E. R., & Arancio, O. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11285 · Cited by 1,035
Huang, H.-C., Nguyen, T., & Pickett, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206911200 · Cited by 1,034 · cited 2×
“Estrogen receptor-positive MCF7 breast cancer cells demonstrate overexpression of DPP3 which is associated with increased Nrf2 gene expression and poor prognosis [100].”
BackgroundWakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M.-I., Kobayashi, A., Yamamoto, M., Kensler, T. W., & Talalay, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307301101 · Cited by 986 · cited 1×
“Dissociation of Nrf2 from Keap1 occurs through the oxidative modification of specific stress-sensing cysteine residues of Keap1 (Figure 6) [55].”
BackgroundKobayashi, A., Kang, M.-I., Watai, Y., Tong, K. I., Shibata, T., Uchida, K., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.221-229.2006 · Cited by 933 · cited 2×
“On the other hand, the Keap1-Nrf2 association may remain intact via the tight-binding ETGE motif even though ubiquitination is impaired without DLG binding [56,58].”
BackgroundValavanidis, A., Vlachogianni, T., Fiotakis, K., & Loridas, S. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10093886 · Cited by 910
Oxidative stress in Alzheimer’s disease
Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., & Perry, G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00040-5 · Cited by 895
Oxidative stress and Parkinson’s disease
Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00091 · Cited by 878 · cited 1×
“Oxidative damage has been implicated in all major neurodegenerative diseases including Alzheimer’s disease (AD) [108,109], Parkinson’s disease (PD) [110,111], Huntington’s disease (HD) [112,113], amyotrophic lateral sclerosis (ALS) [114], and multiple sclerosis (MS) [115].”
BackgroundLau, A., Wang, X.-J., Zhao, F., Villeneuve, N. F., Wu, T., Jiang, T., Sun, Z., White, E., & Zhang, D. D. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00248-10 · Cited by 849
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Wang, X.-J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn095 · Cited by 839
Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837 · cited 1×
“Notably, p62 contains ARE sequences in its promoter and is thereby regulated by Nrf2, indicating a positive feedback loop [79].”
BackgroundRole of Oxidative Stress in Parkinson's Disease
Hwang, O. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.11 · Cited by 835 · cited 1×
“Oxidative damage has been implicated in all major neurodegenerative diseases including Alzheimer’s disease (AD) [108,109], Parkinson’s disease (PD) [110,111], Huntington’s disease (HD) [112,113], amyotrophic lateral sclerosis (ALS) [114], and multiple sclerosis (MS) [115].”
BackgroundReactive oxygen species in health and disease
Alfadda, A. A., & Sallam, R. M. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/936486 · Cited by 824
Lost in Transcription: p21 Repression, Mechanisms, and Consequences
Gartel, A. L., & Radhakrishnan, S. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3995 · Cited by 818 · cited 2×
“, a quiescent, non-dividing stage) due to activation of the p53-regulated cyclin-dependent kinase inhibitor p21, which halts cell cycle progression and inhibits DNA synthesis [23,24].”
BackgroundClements, C. M., McNally, R. S., Conti, B. J., Mak, T. W., & Ting, J. P.-Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607260103 · Cited by 818 · cited 3×
“In both primary human cells and mice, loss of DJ-1 leads to deficits in the expression of Nrf2-mediated stress response enzymes, particularly the detoxification enzyme NQO1, suggesting that DJ-1 is required for Nrf2 stability and Nrf2-mediated transcription [81].”
BackgroundInfluentialOxidative stress response and Nrf2 signaling in aging
Zhang, H., Davies, K. J. A., & Forman, H. J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.036 · Cited by 804
Oxidative Stress in Neurodegenerative Diseases
Niedzielska, E., Smaga, I., Gawlik, M., Moniczewski, A., Stankowicz, P., Pera, J., & Filip, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9337-5 · Cited by 800 · cited 1×
“The brain consumes 20% of the body’s oxygen relative to its small mass (~2% of total body mass) and is particularly susceptible to oxidative damage due to its high rate of metabolic activity, high rate of oxygen metabolite production, relatively low levels of antioxidants, low capacity for repair, and high composition…”
BackgroundStress-activated cap’n’collar transcription factors in aging and human disease
Sykiotis, G. P., & Bohmann, D. (2010) · Science Signaling · doi:10.1126/scisignal.3112re3 · Cited by 776 · cited 5×
“Progressive and irreversible oxidative damage accumulates with age and diminishes critical aspects of cell physiology [57,201,202].”
BackgroundInfluentialSuh, J. H., Shenvi, S. V., Dixon, B. M., Liu, H., Jaiswal, A. K., Liu, R.-M., & Hagen, T. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400282101 · Cited by 772
An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen
Chan, K., Han, X.-D., & Kan, Y. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081082098 · Cited by 770
Beal, M. F. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00780-3 · Cited by 763
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760
Rada, P., Rojo, A. I., Chowdhry, S., McMahon, M., Hayes, J. D., & Cuadrado, A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01204-10 · Cited by 759
Tong, K. I., Katoh, Y., Kusunoki, H., Itoh, K., Tanaka, T., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2887-2900.2006 · Cited by 759
Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis
Li, W., Khor, T. O., Xu, C., Shen, G., Jeong, W.-S., Yu, S., & Kong, A.-N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.017 · Cited by 738
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
Padmanabhan, B., Tong, K. I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.-I., Kobayashi, A., Yokoyama, S., & Yamamoto, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.013 · Cited by 735
Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728
Enomoto, A. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.1.169 · Cited by 728
ALLANBUTTERFIELD, D., CASTEGNA, A., LAUDERBACK, C., & DRAKE, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715 · cited 1×
“The brain consumes 20% of the body’s oxygen relative to its small mass (~2% of total body mass) and is particularly susceptible to oxidative damage due to its high rate of metabolic activity, high rate of oxygen metabolite production, relatively low levels of antioxidants, low capacity for repair, and high composition…”
BackgroundChen, Y., McMillan-Ward, E., Kong, J., Israels, S. J., & Gibson, S. B. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402233 · Cited by 688 · cited 1×
“Depending on the nature of the exposure, cells can activate adaptive cell survival pathways; however, chronic exposure or excessively high levels of ROS may result in the induction of maladaptive autophagic or apoptotic pathways [27,28].”
BackgroundToward clinical application of the Keap1-Nrf2 pathway
Suzuki, T., Motohashi, H., & Yamamoto, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.005 · Cited by 680
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014275108 · Cited by 673
Roh, J.-L., Kim, E. H., Jang, H., & Shin, D. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.010 · Cited by 662
Regulation of Reactive Oxygen Species Generation in Cell Signaling
Bae, Y. S., Oh, H., Rhee, S. G., & Yoo, Y. D. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0276-3 · Cited by 658 · cited 1×
“At low to moderate levels, ROS plays an important role in normal cellular processes, serving as secondary messengers in intracellular signalling cascades that mediate cell growth, autophagy, inflammatory and immune function, and contribute to overall redox regulation [16,17].”
BackgroundChowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A., & Hayes, J. D. (2013) · Oncogene · doi:10.1038/onc.2012.388 · Cited by 657 · cited 7×
“Similar to Neh2, Neh6 contains two highly conserved 334DSGIS338 and 373DSAPGS378 motifs to which the β-transducin repeat-containing protein (βTrCP) binds, and within the DSGIS motif, a phosphorylation site for glycogen synthase kinase-3 (GSK3) that enhances βTrCP activity upon GSK3-mediated phosphorylation of Nrf2 [62…”
BackgroundInfluentialRole of peroxisomes in ros/rns-metabolism: Implications for human disease
Fransen, M., Nordgren, M., Wang, B., & Apanasets, O. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.001 · Cited by 644 · cited 1×
“Peroxisomes also generate ROS from aerobic metabolism [14], and phagocytic neutrophils and macrophages produce ROS to eliminate invading pathogens [15].”
BackgroundDirect Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
Chen, W., Sun, Z., Wang, X.-J., Jiang, T., Huang, Z., Fang, D., & Zhang, D. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.029 · Cited by 638 · cited 6×
“stress requires Nrf2, as colorectal cancer HCT116 cells overexpressing p21 demonstrate enhanced survival in response to hydrogen peroxide in Nrf2+/+ but not Nrf2−/− cells [26].”
BackgroundInfluentialOffen, D., Gilgun-Sherki, Y., & Melamed, E. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0348-9 · Cited by 638
Nguyen, T., Sherratt, P. J., Huang, H.-C., Yang, C. S., & Pickett, C. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207293200 · Cited by 615 · cited 2×
“Under basal conditions, Nrf2 has a short half-life of only 10–30 min [50,77].”
BackgroundBioenergetics and the formation of mitochondrial reactive oxygen species
Adam-Vizi, V., & Chinopoulos, C. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.10.005 · Cited by 610
Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling
Lo, S., Li, X., Henzl, M. T., Beamer, L. J., & Hannink, M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601243 · Cited by 604
Chen, P.-C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813361106 · Cited by 579
Superoxide dismutases—A review of the metal-associated mechanistic variations
Abreu, I. A., & Cabelli, D. E. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.005 · Cited by 563 · cited 1×
“SOD isoenzymes include Cu/Zn-SOD (SOD1), Mn-SOD (SOD2), and extracellular (EC) SOD (SOD3) [31,32].”
BackgroundLon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism
Bota, D. A., & Davies, K. J. A. (2002) · Nature Cell Biology · doi:10.1038/ncb836 · Cited by 557
The definition and measurement of antioxidants in biological systems
Halliwell, B., & Gutteridge, J. M. C. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)91457-3 · Cited by 539 · cited 1×
“Halliwell and Gutteridge have defined antioxidants as “any substance that, when present in low concentrations compared to that of an oxidizable substrate, significantly delays or inhibits the oxidation of that substrate” [30].”
BackgroundDirect and indirect antioxidant properties of inducers of cytoprotective proteins
Dinkova-Kostova, A. T., & Talalay, P. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700195 · Cited by 535
Bennett, J. M., Reeves, G., Billman, G. E., & Sturmberg, J. P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00316 · Cited by 531
The KEAP1–NRF2 System in Cancer
Taguchi, K., & Yamamoto, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00085 · Cited by 527
Katoh, Y., Itoh, K., Yoshida, E., Miyagishi, M., Fukamizu, A., & Yamamoto, M. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00469.x · Cited by 520 · cited 4×
“Neh1 DNA-binding via the ARE; dimerization with sMaf proteins sMaf, ARE [44,48] Neh2 Keap1-binding for negative regulation Keap1 [49,58] Neh3 Transactivation CHD6 [59] Neh4, Neh5 Transactivation CBP [60,61] Neh6 βTrCP-binding for negative regulation βTrCP [62,63] Neh7 RXRα-binding for suppressed transactivation RXRα […”
BackgroundInfluentialOxidative stress in Huntington’s disease
Browne, S. E., Ferrante, R. J., & Beal, M. F. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00216.x · Cited by 508
NIOI, P., McMAHON, M., ITOH, K., YAMAMOTO, M., & HAYES, J. D. (2003) · Biochemical Journal · doi:10.1042/bj20030754 · Cited by 507 · cited 4×
“HeLa cells overexpressing ProTα show increased Nrf2-mediated HMOX1 gene expression; however, overexpression of a mutant variant of ProTα that impairs Keap1-binding fails to upregulate HMOX1 [82], thereby demonstrating the role of ProTα in the expression of certain antioxidant genes.”
BackgroundInfluentialVargas, M. R., Johnson, D. A., Sirkis, D. W., Messing, A., & Johnson, J. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4099-08.2008 · Cited by 479
Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target
Barber, S. C., Mead, R. J., & Shaw, P. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.008 · Cited by 474
The redox stress hypothesis of aging
Sohal, R. S., & Orr, W. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.445 · Cited by 473
Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism
Tong, K. I., Kobayashi, A., Katsuoka, F., & Yamamoto, M. (2006) · Biological Chemistry · doi:10.1515/bc.2006.164 · Cited by 473 · cited 3×
“The N-terminal Neh2 domain is a redox-sensitive degron that negatively regulates Nrf2 activity and contains two highly conserved 29DLG31 and 79ETGE82 motifs to which Keap1 binds, as well as seven lysine residues that are targets for ubiquitination by the Cul3 E3 ubiquitin ligase [49,65].”
BackgroundNg, C. J., Wadleigh, D. J., Gangopadhyay, A., Hama, S., Grijalva, V. R., Navab, M., Fogelman, A. M., & Reddy, S. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105660200 · Cited by 466 · cited 1×
“PON2 has been shown to prevent oxidation and modification of low-density lipoproteins and also counteract lipid peroxidation in the plasma membrane [34].”
BackgroundStewart, D., Killeen, E., Naquin, R., Alam, S., & Alam, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209195200 · Cited by 463 · cited 1×
“Under basal conditions, Nrf2 has a short half-life of only 10–30 min [50,77].”
BackgroundMcMahon, M., Lamont, D. J., Beattie, K. A., & Hayes, J. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007387107 · Cited by 443 · cited 1×
“Additional cysteine residues that respond to redox-active agents include the Cys288 alkenal sensor, the zinc sensor comprised of His225, Cys226, and Cys613, and the nitric oxide sensor comprised of a cluster of basic amino acids (His129, Lys131, Arg135, Lys150, and His154) that facilitate the S-nitrosylation of Cys151…”
BackgroundTong, K. I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S., & Yamamoto, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00753-07 · Cited by 442 · cited 1×
“Notably, the ETGE motif has a binding affinity that is two orders of magnitude higher than that of the DLG motif due to the presence of additional electrostatic interactions [75].”
BackgroundThe role of oxidative stress in the pathophysiology of hypertension
Rodrigo, R., González, J., & Paoletto, F. (2011) · Hypertension Research · doi:10.1038/hr.2010.264 · Cited by 436
Redox regulation by NRF2 in aging and disease
Schmidlin, C. J., Dodson, M. B., Madhavan, L., & Zhang, D. D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.016 · Cited by 434
Nabel, E. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035098 · Cited by 431
Chen, X.-L., Dodd, G., Thomas, S., Zhang, X., Wasserman, M. A., Rovin, B. H., & Kunsch, C. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00651.2005 · Cited by 418
Dhakshinamoorthy, S., Jain, A. K., Bloom, D. A., & Jaiswal, A. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500166200 · Cited by 414 · cited 2×
“Dipeptidyl-peptidase 3 (DPP3) participates in the cleavage and degradation of bioactive peptides generated by the proteasome during protein degradation [98,99].”
BackgroundActivators and inhibitors of NRF2: a review of their potential for clinical development
Robledinos-Antón, N., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9372182 · Cited by 413
Braun, S., Hanselmann, C., Gassmann, M. G., auf dem Keller, U., Born-Berclaz, C., Chan, K., Kan, Y. W., & Werner, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5492-5505.2002 · Cited by 410
Itoh, K., Mochizuki, M., Ishii, Y., Ishii, T., Shibata, T., Kawamoto, Y., Kelly, V., Sekizawa, K., Uchida, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.36-45.2004 · Cited by 407
Relationship Between the Occurrence of Cysteine in Proteins and the Complexity of Organisms
Miseta, A., & Csutora, P. (2000) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a026406 · Cited by 397 · cited 1×
“Intriguingly, Keap1 contains a very high content of cysteines, with the 27 cysteine residues in human Keap1 accounting for approximately 4% of its total amino acid content, which is notably greater than the 2% average for the human proteome [71].”
BackgroundWang, H., Liu, K., Geng, M., Gao, P., Wu, X., Hai, Y., Li, Y., Li, Y., Luo, L., Hayes, J. D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3386 · Cited by 382 · cited 9×
“Retinoid X receptor alpha (RXRα) is involved in numerous developmental and physiological pathways and in mediating the biological effects of retinoids [94].”
BackgroundInfluentialThe Carboxy-Terminal Neh3 Domain of Nrf2 Is Required for Transcriptional Activation
Nioi, P., Nguyen, T., Sherratt, P. J., & Pickett, C. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.10895-10906.2005 · Cited by 381 · cited 4×
“The C-terminal Neh3 domain is a transactivation domain responsible for the transcriptional activation (transactivation) of Nrf2 and has been shown to interact with chromodomain helicase DNA-binding protein 6 (CHD6) which plays a role in chromatin remodelling [59].”
BackgroundInfluentialThe Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm
Zipper, L. M., & Mulcahy, R. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206530200 · Cited by 366 · cited 1×
“Nrf2 association requires the homodimerization of Keap1 [74].”
BackgroundOxidative killing of microbes by neutrophils
Roos, D., van Bruggen, R., & Meischl, C. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.09.009 · Cited by 358 · cited 1×
“Peroxisomes also generate ROS from aerobic metabolism [14], and phagocytic neutrophils and macrophages produce ROS to eliminate invading pathogens [15].”
BackgroundThe role of Nrf2 signaling in counteracting neurodegenerative diseases
Dinkova‐Kostova, A. T., Kostov, R. V., & Kazantsev, A. G. (2018) · The FEBS Journal · doi:10.1111/febs.14379 · Cited by 342
Reactive Nitrogen Species: Molecular Mechanisms and Potential Significance in Health and Disease
Martínez, M. C., & Andriantsitohaina, R. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1993 · Cited by 324
Cytokine Research in Depression: Principles, Challenges, and Open Questions
Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00030 · Cited by 313
Retinoid X receptors: X-ploring their (patho)physiological functions
Szanto, A., Narkar, V, Shen, Q., Uray, I. P., Davies, P. J. A., & Nagy, L. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401533 · Cited by 302
PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria
Lo, S.-C., & Hannink, M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.02.014 · Cited by 300 · cited 2×
“Interestingly, PGAM5 can recruit both Keap1 and Nrf2 to the outer mitochondrial membrane by binding to one molecule of a Keap1 dimer while simultaneously binding Nrf2 to form a ternary Keap1-PGAM5-Nrf2 complex [102,103].”
BackgroundFreigang, S., Ampenberger, F., Spohn, G., Heer, S., Shamshiev, A. T., Kisielow, J., Hersberger, M., Yamamoto, M., Bachmann, M. F., & Kopf, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041316 · Cited by 300
Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust
Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K., & Yamamoto, M. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9176 · Cited by 297
Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response
Saito, R., Suzuki, T., Hiramoto, K., Asami, S., Naganuma, E., Suda, H., Iso, T., Yamamoto, H., Morita, M., Baird, L., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00868-15 · Cited by 294 · cited 2×
“[72], who also found some inducers to function independently of these three specific cysteines.”
BackgroundBRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival
Gorrini, C., Baniasadi, P. S., Harris, I. S., Silvester, J., Inoue, S., Snow, B., Joshi, P. A., Wakeham, A., Molyneux, S. D., Martin, B., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121337 · Cited by 289 · cited 8×
“HeLa cells overexpressing ProTα show increased Nrf2-mediated HMOX1 gene expression; however, overexpression of a mutant variant of ProTα that impairs Keap1-binding fails to upregulate HMOX1 [82], thereby demonstrating the role of ProTα in the expression of certain antioxidant genes.”
BackgroundInfluentialMolecular Mechanism of Cellular Oxidative Stress Sensing by Keap1
Suzuki, T., Muramatsu, A., Saito, R., Iso, T., Shibata, T., Kuwata, K., Kawaguchi, S.-I., Iwawaki, T., Adachi, S., Suda, H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.047 · Cited by 287
High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
Jiang, T., Chen, N., Zhao, F., Wang, X.-J., Kong, B., Zheng, W., & Zhang, D. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0713 · Cited by 286
Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases
Canning, P., Cooper, C. D. O., Krojer, T., Murray, J. W., Pike, A. C. W., Chaikuad, A., Keates, T., Thangaratnarajah, C., Hojzan, V., Marsden, B. D., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437996 · Cited by 284 · cited 4×
“Cul3 assembly requires a “3-box” motif that is characteristic of BTB-Kelch proteins [67].”
BackgroundInfluentialProteostasis and the Aging Proteome in Health and Disease
Morimoto, R. I., & Cuervo, A. M. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu049 · Cited by 277
Brugarolas, J., Moberg, K., Boyd, S. D., Taya, Y., Jacks, T., & Lees, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1002 · Cited by 276 · cited 2×
“ROS can also trigger the p53 and p21-mediated dephosphorylation and activation of the tumour-suppressor retinoblastoma protein (Rb) resulting in further inhibition of cell cycle progression [25].”
BackgroundUngvari, Z., Bailey-Downs, L., Sosnowska, D., Gautam, T., Koncz, P., Losonczy, G., Ballabh, P., de Cabo, R., Sonntag, W. E., & Csiszar, A. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01134.2010 · Cited by 274
Copple, I. M., Lister, A., Obeng, A. D., Kitteringham, N. R., Jenkins, R. E., Layfield, R., Foster, B. J., Goldring, C. E., & Park, B. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.096545 · Cited by 260 · cited 3×
“WTX is also involved in oxidative stress regulation through its competitive binding to the Keap1, which inhibits Nrf2 ubiquitination [84].”
BackgroundInfluentialFukutomi, T., Takagi, K., Mizushima, T., Ohuchi, N., & Yamamoto, M. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01191-13 · Cited by 260 · cited 1×
“The DLG motif utilizes hydrogen bonding whereas the ETGE motif utilizes both hydrophobic interactions and hydrogen bonding [76].”
BackgroundHast, B. E., Goldfarb, D., Mulvaney, K. M., Hast, M. A., Siesser, P. F., Yan, F., Hayes, D. N., & Major, M. B. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4400 · Cited by 259
Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
Cleasby, A., Yon, J., Day, P. J., Richardson, C., Tickle, I. J., Williams, P. A., Callahan, J. F., Carr, R., Concha, N., Kerns, J. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098896 · Cited by 258 · cited 1×
“The N-terminal BTB (broad complex, tramtrack, and bric à brac) domain mediates Keap1 homodimerization and contributes to its interaction with Cul3 [68].”
BackgroundSmaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegaliński, E., Pera, J., & Filip, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.015 · Cited by 252
Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy
Fan, W., Tang, Z., Chen, D., Moughon, D., Ding, X., Chen, S., Zhu, M., & Zhong, Q. (2010) · Autophagy · doi:10.4161/auto.6.5.12189 · Cited by 251 · cited 1×
“Like the WTX protein, PALB2 contains a 91ETGE94 motif that permits its interaction with Keap1 through binding to the Kelch domain [85].”
BackgroundCalkins, M. J., Jakel, R. J., Johnson, D. A., Chan, K., Kan, Y. W., & Johnson, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408487101 · Cited by 247
Oxidative Stress and Huntington’s Disease: The Good, the Bad, and the Ugly
Kumar, A., & Ratan, R. R. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160205 · Cited by 236
Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress
Bota, D. A., Van Remmen, H., & Davies, K. J. A. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03638-4 · Cited by 233
Olayanju, A., Copple, I. M., Bryan, H. K., Edge, G. T., Sison, R. L., Wong, M. W., Lai, Z.-Q., Lin, Z.-X., Dunn, K., Sanderson, C. M., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.11.003 · Cited by 232
The Keap1-Nrf2 system and diabetes mellitus
Uruno, A., Yagishita, Y., & Yamamoto, M. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.12.012 · Cited by 231
Ungvari, Z., Bailey-Downs, L., Gautam, T., Sosnowska, D., Wang, M., Monticone, R. E., Telljohann, R., Pinto, J. T., de Cabo, R., Sonntag, W. E., et al. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr092 · Cited by 226
Shibata, T., Kokubu, A., Saito, S., Narisawa-Saito, M., Sasaki, H., Aoyagi, K., Yoshimatsu, Y., Tachimori, Y., Kushima, R., Kiyono, T., et al. (2011) · Neoplasia · doi:10.1593/neo.11750 · Cited by 224
Antioxidants as potential therapeutics for neuropsychiatric disorders
Pandya, C. D., Howell, K. R., & Pillai, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.017 · Cited by 222
Rushworth, S. A., MacEwan, D. J., & O’Connell, M. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6730 · Cited by 215
Possible role of oxidative stress in the pathogenesis of hypertension
Ceriello, A. (2008) · Diabetes Care · doi:10.2337/dc08-s245 · Cited by 215
Nakata, K., Tanaka, Y., Nakano, T., Adachi, T., Tanaka, H., Kaminuma, T., & Ishikawa, T. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.437 · Cited by 215 · cited 1×
“Xenobiotic metabolism consists of phase I, phase II, and phase III enzymes involved in oxidation, conjugation/detoxification, and elimination, respectively [40,41].”
BackgroundA mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
Nioi, P., & Nguyen, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.051 · Cited by 212
Nrf2 signaling is impaired in the aging RPE given an oxidative insult
Sachdeva, M. M., Cano, M., & Handa, J. T. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2013.10.024 · Cited by 207
Role of Nrf2 in aging, Alzheimer’s and other neurodegenerative diseases
George, M., Tharakan, M., Culberson, J., Reddy, A. P., & Reddy, P. H. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101756 · Cited by 207
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., & Broersen, K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190863 · Cited by 204 · cited 1×
“Oxidative damage has been implicated in all major neurodegenerative diseases including Alzheimer’s disease (AD) [108,109], Parkinson’s disease (PD) [110,111], Huntington’s disease (HD) [112,113], amyotrophic lateral sclerosis (ALS) [114], and multiple sclerosis (MS) [115].”
BackgroundLo, S.-C., & Hannink, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606539200 · Cited by 199 · cited 3×
“siRNA knockdown of PALB2 in bone-derived U2OS cells results in reduced Nrf2 activity and increased ROS levels [103].”
BackgroundAn Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases
Zgorzynska, E., Dziedzic, B., & Walczewska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179592 · Cited by 198 · cited 1×
“The current status of Nrf2 in neurodegenerative disease is comprehensively reviewed by Zgorzynska et al. (2021) [123], Cuadrado (2022) [124], George et al. (2022) [125].”
BackgroundOxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives
Tanase, D. M., Gosav, E. M., Anton, M. I., Floria, M., Seritean Isac, P. N., Hurjui, L. L., Tarniceriu, C. C., Costea, C. F., Ciocoiu, M., & Rezus, C. (2022) · Biomolecules · doi:10.3390/biom12091227 · Cited by 198 · cited 1×
“Refer to Uruno et al. (2015) [156] and Tanase et al. (2022) [157] for additional details on Nrf2 in diabetes.”
BackgroundThe KEAP1–NRF2 System as a Molecular Target of Cancer Treatment
Taguchi, K., & Yamamoto, M. (2020) · Cancers · doi:10.3390/cancers13010046 · Cited by 195
Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages
Lara-Guzmán, O. J., Gil-Izquierdo, Á., Medina, S., Osorio, E., Álvarez-Quintero, R., Zuluaga, N., Oger, C., Galano, J.-M., Durand, T., & Muñoz-Durango, K. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.017 · Cited by 194
Muller, F. (2000) · AGE · doi:10.1007/s11357-000-0022-9 · Cited by 193
PALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function
Ma, J., Cai, H., Wu, T., Sobhian, B., Huo, Y., Alcivar, A., Mehta, M., Cheung, K. L., Ganesan, S., Kong, A.-N. T., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06271-11 · Cited by 192 · cited 2×
“Keap1 p62/SQSTM1 349DPSTGE354 (p62) Kelch +; Keap1 inhibition [84–88] ProTα/PTMA 38NANEENGE45 (ProTα) Kelch +; Keap1 inhibition [89] DPP3 480ETGE483 (DPP3) Kelch +; Keap1 inhibition [90] WTX 286SPETGE291 (WTX) Kelch +; Keap1 inhibition [91] PALB2/FANCN 91ETGE94 (PALB2) BTB +; Keap1 inhibition [92] KPNA6/Importin α7 AR…”
BackgroundZhang, J.-C., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., & Hashimoto, K. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.112 · Cited by 182
Proteostasis collapse is a driver of cell aging and death
Santra, M., Dill, K. A., & de Graff, A. M. R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906592116 · Cited by 175
Karapetian, R. N., Evstafieva, A. G., Abaeva, I. S., Chichkova, N. V., Filonov, G. S., Rubtsov, Y. P., Sukhacheva, E. A., Melnikov, S. V., Schneider, U., Wanker, E. E., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1089-1099.2005 · Cited by 173 · cited 1×
“Keap1 p62/SQSTM1 349DPSTGE354 (p62) Kelch +; Keap1 inhibition [84–88] ProTα/PTMA 38NANEENGE45 (ProTα) Kelch +; Keap1 inhibition [89] DPP3 480ETGE483 (DPP3) Kelch +; Keap1 inhibition [90] WTX 286SPETGE291 (WTX) Kelch +; Keap1 inhibition [91] PALB2/FANCN 91ETGE94 (PALB2) BTB +; Keap1 inhibition [92] KPNA6/Importin α7 AR…”
Roles of BRCA1 in DNA damage repair: a link between development and cancer
Deng, C.-X. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg082 · Cited by 168 · cited 2×
“Breast cancer type 1 susceptibility protein (BRCA1) is a tumour suppressor protein primarily responsible for DNA damage repair in cells of the breast and other tissue [97].”
BackgroundNeuropathology of mood disorders: Do we see the stigmata of inflammation?
Mechawar, N., & Savitz, J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.212 · Cited by 165
Nrf2 as a Potential Mediator of Cardiovascular Risk in Metabolic Diseases
da Costa, R. M., Rodrigues, D., Pereira, C. A., Silva, J. F., Alves, J. V., Lobato, N. S., & Tostes, R. C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00382 · Cited by 165
Zhu, J., Wang, H., Chen, F., Fu, J., Xu, Y., Hou, Y., Kou, H. H., Zhai, C., Nelson, M. B., Zhang, Q., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.09.010 · Cited by 162
Zondler, L., Miller-Fleming, L., Repici, M., Gonçalves, S., Tenreiro, S., Rosado-Ramos, R., Betzer, C., Straatman, K. R., Jensen, P. H., Giorgini, F., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.307 · Cited by 161 · cited 2×
“Protein deglycase DJ-1 (DJ-1) (also known as Park7) is a redox-dependent molecular chaperone that mediates protein folding and prevents the misfolding and inclusion formation of neuronal proteins such as α-Synuclein [95].”
BackgroundOoi, A., Dykema, K., Ansari, A., Petillo, D., Snider, J., Kahnoski, R., Anema, J., Craig, D., Carpten, J., Teh, B.-T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3227 · Cited by 159
Yao, W., Zhang, J.-C., Ishima, T., Dong, C., Yang, C., Ren, Q., Ma, M., Han, M., Wu, J., Suganuma, H., et al. (2016) · Scientific Reports · doi:10.1038/srep30659 · Cited by 154
Zhou, L., Zhang, H., Davies, K. J. A., & Forman, H. J. (2018) · Redox Biology · doi:10.1016/j.redox.2017.08.014 · Cited by 145
Nrf2 participates in depressive disorders through an anti-inflammatory mechanism
Martín-de-Saavedra, M. D., Budni, J., Cunha, M. P., Gómez-Rangel, V., Lorrio, S., del Barrio, L., Lastres-Becker, I., Parada, E., Tordera, R. M., Rodrigues, A. L. S., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.020 · Cited by 143
A catalogue of somatic NRF2 gain-of-function mutations in cancer
Kerins, M. J., & Ooi, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-31281-0 · Cited by 140
Valcarcel-Ares, M. N., Gautam, T., Warrington, J. P., Bailey-Downs, L., Sosnowska, D., de Cabo, R., Losonczy, G., Sonntag, W. E., Ungvari, Z., & Csiszar, A. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr229 · Cited by 139
IKEDA, H., NISHI, S., & SAKAI, M. (2004) · Biochemical Journal · doi:10.1042/bj20031948 · Cited by 136
Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy
Li, B., Liu, S., Miao, L., & Cai, L. (2012) · Experimental Diabetes Research · doi:10.1155/2012/216512 · Cited by 133
Emanuelli, M., Sartini, D., Molinelli, E., Campagna, R., Pozzi, V., Salvolini, E., Simonetti, O., Campanati, A., & Offidani, A. (2022) · Antioxidants · doi:10.3390/antiox11040612 · Cited by 132
Camp, N. D., James, R. G., Dawson, D. W., Yan, F., Davison, J. M., Houck, S. A., Tang, X., Zheng, N., Major, M. B., & Moon, R. T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.316471 · Cited by 129 · cited 1×
“Keap1 p62/SQSTM1 349DPSTGE354 (p62) Kelch +; Keap1 inhibition [84–88] ProTα/PTMA 38NANEENGE45 (ProTα) Kelch +; Keap1 inhibition [89] DPP3 480ETGE483 (DPP3) Kelch +; Keap1 inhibition [90] WTX 286SPETGE291 (WTX) Kelch +; Keap1 inhibition [91] PALB2/FANCN 91ETGE94 (PALB2) BTB +; Keap1 inhibition [92] KPNA6/Importin α7 AR…”
Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway
Tossetta, G., & Marzioni, D. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106365 · Cited by 115
Nitrosative Stress and Transcription
Kröncke, K.-D. (2003) · Biological Chemistry · doi:10.1515/bc.2003.153 · Cited by 115
The absence of macrophage Nrf2 promotes early atherogenesis
Ruotsalainen, A.-K., Inkala, M., Partanen, M. E., Lappalainen, J. P., Kansanen, E., Mäkinen, P. I., Heinonen, S. E., Laitinen, H. M., Heikkilä, J., Vatanen, T., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt008 · Cited by 109
Kim, J.-H., Yu, S., Chen, J. D., & Kong, A. N. (2013) · Oncogene · doi:10.1038/onc.2012.59 · Cited by 108
Ma, Q., Kinneer, K., Ye, J., & Chen, B. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.211 · Cited by 107
Cited by
Interplay of oxidative stress, cellular communication and signaling pathways in cancer
Iqbal, M. J., Kabeer, A., Abbas, Z., Siddiqui, H. A., Calina, D., Sharifi-Rad, J., & Cho, W. C. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01398-5 · Cited by 418
“3) [7, 36].”
BackgroundRedox Imbalance in Inflammation: The Interplay of Oxidative and Reductive Stress
Bellanti, F., Coda, A. R. D., Trecca, M. I., Lo Buglio, A., Serviddio, G., & Vendemiale, G. (2025) · Antioxidants · doi:10.3390/antiox14060656 · Cited by 177
“Nrf2 is normally bound to Keap1, which facilitates its ubiquitination and degradation, but OS modifies critical cysteine residues on Keap1, leading to the stabilization and nuclear translocation of Nrf2 [28,29].”
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers
Liang, X., Weng, J., You, Z., Wang, Y., Wen, J., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02375-x · Cited by 219
Fornari Laurindo, L., Aparecido Dias, J., Cressoni Araújo, A., Torres Pomini, K., Machado Galhardi, C., Rucco Penteado Detregiachi, C., Santos de Argollo Haber, L., Donizeti Roque, D., Dib Bechara, M., Vialogo Marques de Castro, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305933 · Cited by 144
Selvaraj, N. R., Nandan, D., Nair, B. J. B., Nair, V. A., Venugopal, P., & Aradhya, R. (2025) · Cells · doi:10.3390/cells14070511 · Cited by 176
“While generally considered protective, elevated Nrf2 activity may, in some cases, promote tumor growth and chemoresistance [289].”
Metadata
- Authors
- Ngo, V., & Duennwald, M. L.
- Affiliations
- Western University (CA)
- Corresponding author
- Duennwald, Martin L.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2022-11-27
- Volume
- 11
- Issue
- 12
- Pages
- 2345
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC9774434
- OpenAlex
- W4310211651
- Semantic Scholar
- ae6aa01efc202b0f3f701cefd15f11f215aa3aa5
- Cited by
- 1,130
- References
- 236
- Citations by year
- 2026: 415 · 2025: 448 · 2024: 200 · 2023: 67
- FWCI
- 18.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- TBCRU (n/a)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Nrf2, oxidative stress, reactive oxygen species, antioxidant defense, antioxidant enzymes, Nrf2 activation, neurodegenerative diseases, cardiovascular disease, diabetes mellitus, cancer, detoxification
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.